Back
Summit Therapeutics Stock Price Chart
Sponsored
SMMT
Sponsored
How to Profit From "America's Earnings" Reports
New Trade Goes LIVE THIS TUESDAY at 2 pm
Buy
79
SMMT
Summit Therapeutics
Last Price:
26.20
Seasonality Move:
26.72%
7 Day Trial
ALL ACCESS PASS
$
7
How this hedge fund manager trades weekly options
Claim your free training on trading weekly options- The current trend is moderately bullish and SMMT is experiencing selling pressure, which indicates risk of future bearish movement.
Summit Therapeutics Price Chart Indicators
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 24.01 | Buy |
20-day SMA: | 17.36 | Buy |
50-day SMA: | 13.03 | Buy |
200-day SMA: | 6.61 | Buy |
8-day EMA: | 24.48 | Buy |
20-day EMA: | 19.28 | Buy |
50-day EMA: | 14.43 | Buy |
200-day EMA: | 8.04 | Buy |
Summit Therapeutics Technical Analysis Indicators
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 4.4 | Buy |
Relative Strength Index (14 RSI): | 69.61 | Buy |
Chaikin Money Flow: | -7453022 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (9.89 - 22.53) | Buy |
Bollinger Bands (100): | (4.23 - 14.99) | Buy |
Summit Therapeutics Technical Analysis
Sep 4 | Sep 5 | Sep 6 | Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | |
---|---|---|---|---|---|---|---|---|---|---|
Sep | ||||||||||
04 | 05 | 06 | 09 | 10 | 11 | 12 | 13 | 16 | 17 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Technical Analysis for Summit Therapeutics Stock
Is Summit Therapeutics Stock a Buy?
- Summit Therapeutics share price is 26.22 while SMMT 8-day simple moving average is 24.01, which is a Buy signal.
- The stock price of SMMT is 26.22 while Summit Therapeutics 20-day SMA is 17.36, which makes it a Buy.
- Summit Therapeutics 50-day simple moving average is 13.03 while SMMT share price is 26.22, making it a Buy technically.
- SMMT stock price is 26.22 and Summit Therapeutics 200-day simple moving average is 6.61, creating a Buy signal.
SMMT Technical Analysis vs Fundamental Analysis
Buy
79
Summit Therapeutics (SMMT)
is a Buy
Is Summit Therapeutics a Buy or a Sell?
-
Summit Therapeutics stock is rated a Buy
The current Summit Therapeutics [SMMT] share price is $26.22. The Score for SMMT is 79, which is 58% above its historic median score of 50, and infers lower risk than normal.
Summit Therapeutics Stock Info
Market Cap:
19.27B
Price in USD:
26.22
Share Volume:
11.48M
Summit Therapeutics 52-Week Range
52-Week High:
33.89
52-Week Low:
1.64
Buy
79
Summit Therapeutics (SMMT)
is a Buy
Summit Therapeutics Share Price Forecast
-
What is the Summit Therapeutics stock price today?
The Summit Therapeutics stock price is 26.22 USD today. -
Will SMMT stock go up or go down?
Summit Therapeutics> share price is forecast to RISE/FALL based on technical indicators -
Is Summit Therapeutics overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Summit Therapeutics is not overvalued.
Is Summit Therapeutics Stock a Buy?
- Summit Therapeutics share price is 26.22 while SMMT 8-day exponential moving average is 24.48, which is a Buy signal.
- The stock price of SMMT is 26.22 while Summit Therapeutics 20-day EMA is 19.28, which makes it a Buy.
- Summit Therapeutics 50-day exponential moving average is 14.43 while SMMT share price is 26.22, making it a Buy technically.
- SMMT stock price is 26.22 and Summit Therapeutics 200-day simple moving average is 8.04, creating a Buy signal.
Fundamental Analysis of Summit Therapeutics
Is Summit Therapeutics a good investment?
- Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.01 per share, an increase this year of $0.32 per share, and a decrease next year of $0.03 per share.
Technical Analysis of Summit Therapeutics
Should I short Summit Therapeutics stock?
- SMMT Moving Average Covergence Divergence (MACD) indicator is 4.4, suggesting Summit Therapeutics is a Buy
- Summit Therapeutics Relative Strength Index (RSI) is 69.61, which suggest Summit Therapeutics is overbought
- The Bollinger Bands (25) for Summit Therapeutics is (9.89 - 22.53), which suggest Summit Therapeutics is a Buy
- The Bollinger Bands (100) for Summit Therapeutics is (4.23 - 14.99), which suggest Summit Therapeutics is a Buy
* Summit Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.